Search Results - "López‐Calvo, Soledad"
-
1
-
2
Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine
Published in Basic & clinical pharmacology & toxicology (01-04-2019)“…Two elvitegravir/cobicistat‐based therapies combined with emtricitabine/tenofovir disoproxil fumarate (EVG/c/FTC/TDF) or emtricitabine/tenofovir alafenamide…”
Get full text
Journal Article -
3
Ileocolonic invagination in an human immunodeficiency virus-positive man
Published in Gastroenterología y hepatología (01-06-2014)Get more information
Journal Article -
4
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study
Published in European journal of hospital pharmacy. Science and practice (01-07-2022)“…ObjectivesDespite the high efficacy of antiretroviral treatment, no drug is free from adverse events (AEs). Efavirenz (EFV) and dolutegravir (DTG) are…”
Get full text
Journal Article -
5
High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response
Published in AIDS (London) (31-07-2014)“…HIV-1 non-B subtype variants were found in 37.8% of 296 newly diagnosed persons in northwest Spain over the past 5 years. Subtype F was the most prevalent…”
Get full text
Journal Article -
6
Total HCV core antigen assay: A new marker of HCV viremia and its application during treatment of chronic hepatitis C
Published in Journal of virological methods (15-09-2004)“…The present study assesses the clinical usefulness of the hepatitis C core antigen assay for monitoring of patients being treated for chronic hepatitis C virus…”
Get full text
Journal Article -
7
Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort
Published in European journal of hospital pharmacy. Science and practice (01-07-2023)“…Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate (EVG/c/FTC/TAF) and dolutegravir/abacavir/lamivudine (DTG/ABC/3TC) are currently available…”
Get full text
Journal Article -
8
Upper gastrointestinal bleeding due to gastric and duodenal Kaposi's sarcoma
Published in Revista española de enfermedades digestivas (01-02-2012)Get full text
Journal Article -
9
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure
Published in Antiviral research (01-02-2020)“…A percentage of hepatitis C virus (HCV)-infected patients fail direct acting antiviral (DAA)-based treatment regimens, often because of drug…”
Get full text
Journal Article -
10
-
11
Total HCV core antigen assay
Published in Journal of virological methods (01-09-2004)Get full text
Journal Article -
12
Upper gastrointestinal bleeding due to gastric and duodenal Kaposi's sarcoma
Published in Revista española de enfermedades digestivas (01-01-2012)Get full text
Journal Article -
13
Resistance mutations in HIV-infected patients experiencing early failure with nelfinavir-containing triple combinations
Published in Medical science monitor (01-09-2002)“…The purpose of our study was to assess the presence of nelfinavir (NFV)-associated resistance mutations at the time of early virological failure in subjects…”
Get more information
Journal Article -
14
Protease inhibitor-related paronychia, ingrown toenails, desquamative cheilitis and cutaneous xerosis
Published in AIDS (London) (16-06-2000)“…Some reports have recently suggested that antiretroviral drugs may cause paronychia of the toes or fingers and ingrown toenails. The drugs involved were…”
Get full text
Journal Article -
15
Telogen effluvium as a clinical presentation of human immunodeficiency virus infection
Published in The American journal of medicine (15-04-2002)Get more information
Journal Article -
16
-
17